文献速递生殖医学

延长排卵触发至卵胞浆内单精子注射间隔对胚胎与临床结局的影响

Expanding the time interval between ovulation triggering and oocyte injection: does it affect the embryological and clinical outcome?
PubMed 文献 · Hum Reprod · 2021-01-01

该单中心回顾性队列分析纳入2010至2015年8811个ICSI周期,按排卵触发至卵子注射间隔分7组(<36h至≥41h)。调整混杂因素后,间隔≥41h组成熟率与受精率显著高于38h参照组,但临床妊娠率和活产率无显著差异;<36h组活产率有降低趋势但未达统计学显著。

要点

  • 延长排卵触发至注射间隔未对临床妊娠率或活产率产生显著影响。
  • ≥41h注射组的调整后成熟率和受精率显著高于38h参照组。
  • <36h注射组活产率有降低趋势(OR 0.533, 95%CI 0.252-1.126, P=0.099),但无统计学意义。

核心结论

  • 扩大排卵触发至卵子剥脱/注射的时间间隔对ICSI胚胎学和临床结局无临床相关影响。

研究设计与样本

  • 单中心回顾性队列分析,纳入2010至2015年8811个ICSI周期,按触发至注射间隔分为<36h、36h、37h、38h、39h、40h和≥41h共7组。

主要发现

  • 调整后平均成熟率范围为76.4%至83.2%,组间差异显著(P < 0.001)。
  • 调整后平均受精率范围为69.2%至79.3%,组间差异显著(P < 0.001)。
  • ≥41h注射组的调整后成熟率和受精率显著高于38h参照组。
  • <36h注射组与38h组相比,成熟率、受精率和胚胎利用率无显著差异。
  • 调整混杂因素后,时间间隔对临床妊娠率和活产率无显著影响;<36h组活产率有降低趋势(OR 0.533, 95%CI 0.252-1.126; P = 0.099),但无统计学意义。

关键数值与推荐

  • 常规取卵在触发后36h进行,<36h组仅在取卵早于计划36h时出现并立即注射。
  • 仅纳入新鲜自体配子周期,排除睾丸/附睾精子注射、自然周期、常规IVF、IVF/ICSI混合、植入前遗传学检测和IVM周期。

临床怎么用

  • 对于工作负荷大的ART中心,注射时间窗可能不如既往认为的那样严格,适度延长间隔未显著影响临床结局。

局限性

  • 回顾性研究设计,无法排除未控制变量的影响。
  • 结果不应外推至IVM、常规IVF或睾丸/附睾精子注射等其他ART操作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is the time interval between ovulation triggering and oocyte denudation/injection associated with embryological and clinical outcome after ICSI? SUMMARY ANSWER: Expanding the time interval between ovulation triggering and oocyte denudation/injection is not associated with any clinically relevant impact on embryological or clinical outcome. WHAT IS KNOWN ALREADY: The optimal time interval between ovulation triggering and insemination/injection appears to be 38-39 h and most authors agree that an interval of >41 h has a negative influence on embryological and clinical pregnancy outcomes. However, in ART centres with a heavy workload, respecting these exact time intervals is frequently challenging. Therefore, we questioned to what extent a wider time interval between ovulation triggering and oocyte injection would affect embryological and clinical outcome in ICSI cycles. STUDY DESIGN, SIZE, DURATION: A single-centre retrospective cohort analysis was performed including 8811 ICSI cycles from 2010 until 2015. Regarding the time interval between ovulation triggering and oocyte injection, seven categories were considered: <36 h, 36 h, 37 h, 38 h, 39 h, 40 h and ≥41 h. In all cases, denudation was performed immediately prior to injection. The main outcome measures were oocyte maturation, fertilization and embryo utilization rate (embryos adequate for transfer or cryopreservation) per fertilized oocyte. Clinical pregnancy rate (CPR) and live birth rate (LBR) were considered as secondary outcomes. Utilization rate, CPR and LBR were subdivided into two groups according to the day of embryo transfer: Day 3 or Day 5. PARTICIPANTS/MATERIALS, SETTING, METHODS: During the study period, oocyte retrieval was routinely performed 36 h post-triggering except in the <36 h group. The interval of <36 h occurred only if OR was carried out before the planned 36 h trigger interval and was followed by immediate injection. Only cycles with fresh autologous gametes were included. The exclusion criteria were: injection with testicular/epididymal sperm, managed natural cycles, conventional IVF, combined conventional IVF/ICSI, preimplantation genetic testing and IVM cycles. Female age, number of oocytes, pre-preparation sperm concentration, post-preparation sperm concentration and motility, day of transfer, number of embryos transferred and quality of the best embryo transferred were identified as potential confounders. MAIN RESULTS AND THE ROLE OF CHANCE: Among the seven interval groups, adjusted mean maturation rates ranged from 76.4% to 83.2% and differed significantly (P < 0.001). Similarly, there was a significant difference in adjusted mean fertilization rates (range 69.2-79.3%; P < 0.001). The adjusted maturation and fertilization rates were significantly higher when denudation/injection was performed >41 h post-triggering compared to 38 h post-triggering (reference group). Oocyte denudation/injection at <36 h post-triggering had no significant effect on maturation, fertilization or embryo utilization rates compared to injection at 38 h. No effect of the time interval was observed on CPRs and LBRs, after adjusting for potential confounders. When oocyte injection was performed before 36 h the adjusted analysis showed that compared to 38 h after ovulation triggering the chance of having a live birth tends to be lower although the difference was not statistically significant (odds ratio 0.533, 95% CI: 0.252-1.126; P = 0.099). Injection ≥41 h post-triggering did not affect LBR compared to injection at 38 h post-ovulation. LIMITATIONS, REASONS FOR CAUTION: As this is a large retrospective study, the influence of uncontrolled variables cannot be excluded. These results should not be extrapolated to other ART procedures such as IVM, conventional IVF or injection with testicular/epididymal sperm. WIDER IMPLICATIONS OF THE FINDINGS: Our results indicate that the optimal injection time window may be less stringent than previously thought as both embryological and clinical outcome parameters were not significantly affected in our analysis. This is reassuring for busy ART centres that might not always be able to follow strict time intervals. STUDY FUNDING/COMPETING INTEREST(S): No funding. The authors declare no conflict of interest related to the present study. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Vandenberghe LTM, Santos-Ribeiro S, De Munck N, et al. Expanding the time interval between ovulation triggering and oocyte injection: does it affect the embryological and clinical outcome? Hum Reprod. 2021. PMID: 33367689. doi:10.1093/humrep/deaa338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。